These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 34577099)

  • 1. The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes.
    Kell DB
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible?
    Kell DB
    Trends Pharmacol Sci; 2015 Jan; 36(1):15-21. PubMed ID: 25458537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so.
    Kell DB; Dobson PD; Bilsland E; Oliver SG
    Drug Discov Today; 2013 Mar; 18(5-6):218-39. PubMed ID: 23207804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of multiple influx and efflux transporters in the accumulation of cationic fluorescent dyes by Escherichia coli.
    Jindal S; Yang L; Day PJ; Kell DB
    BMC Microbiol; 2019 Aug; 19(1):195. PubMed ID: 31438868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum.
    Michiba K; Maeda K; Kurimori K; Enomoto T; Shimomura O; Takeuchi T; Nishiyama H; Oda T; Kusuhara H
    Drug Metab Dispos; 2021 Jan; 49(1):84-93. PubMed ID: 33087448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
    Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Study 8: Status of the Structural Mass Action Kinetic Model of P-gp-Mediated Transport Through Confluent Cell Monolayers.
    Bentz J; Ellens H
    Methods Mol Biol; 2021; 2342():737-763. PubMed ID: 34272715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does transbilayer diffusion have a role in membrane transport of drugs?
    Balaz S
    Drug Discov Today; 2012 Oct; 17(19-20):1079-87. PubMed ID: 22705388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the dominant role of transporters in drug uptake by cells.
    Dobson PD; Lanthaler K; Oliver SG; Kell DB
    Curr Top Med Chem; 2009; 9(2):163-81. PubMed ID: 19200003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Glucose Transporters in Drug Membrane Transport.
    Wang X; Guo K; Huang B; Lin Z; Cai Z
    Curr Drug Metab; 2020; 21(12):947-958. PubMed ID: 32778021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-protein interactions of drug uptake transporters that are important for liver and kidney.
    Zhang Y; Hagenbuch B
    Biochem Pharmacol; 2019 Oct; 168():384-391. PubMed ID: 31381872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
    Dobson PD; Kell DB
    Nat Rev Drug Discov; 2008 Mar; 7(3):205-20. PubMed ID: 18309312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and Permeability Studies to Delineate the Role of Efflux Transporters.
    Vadlapatla RK; Pal D; Mitra AK
    Methods Mol Biol; 2016; 1395():69-74. PubMed ID: 26910069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Similarities between Some Common Fluorophores Used in Biology, Marketed Drugs, Endogenous Metabolites, and Natural Products.
    O'Hagan S; Kell DB
    Mar Drugs; 2020 Nov; 18(11):. PubMed ID: 33238416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting intestinal transporters for optimizing oral drug absorption.
    Varma MV; Ambler CM; Ullah M; Rotter CJ; Sun H; Litchfield J; Fenner KS; El-Kattan AF
    Curr Drug Metab; 2010 Nov; 11(9):730-42. PubMed ID: 21189135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial anion transporters in bilayer membranes.
    Licen S; De Riccardis F; Izzo I; Tecilla P
    Curr Drug Discov Technol; 2008 Jun; 5(2):86-97. PubMed ID: 18673247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug trafficking: recent advances in therapeutics and disease.
    Sprowl JA; Sparreboom A
    Clin Pharmacol Ther; 2012 Nov; 92(5):531-4. PubMed ID: 23085872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular expression and functional activity of efflux and influx transporters in hypoxia induced retinal pigment epithelial cells.
    Vadlapatla RK; Vadlapudi AD; Ponnaluri VK; Pal D; Mukherji M; Mitra AK
    Int J Pharm; 2013 Sep; 454(1):444-52. PubMed ID: 23827654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational changes of the multispecific transporter organic anion transporter 1 (OAT1/SLC22A6) suggests a molecular mechanism for initial stages of drug and metabolite transport.
    Tsigelny IF; Kovalskyy D; Kouznetsova VL; Balinskyi O; Sharikov Y; Bhatnagar V; Nigam SK
    Cell Biochem Biophys; 2011 Nov; 61(2):251-9. PubMed ID: 21499753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and Toxicokinetics Roles of Membrane Transporters at Kidney Level.
    Veiga-Matos J; Remião F; Motales A
    J Pharm Pharm Sci; 2020; 23():333-356. PubMed ID: 32997956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.